MedPath
TGA Approval

FABRAZYME agalsidase beta-rch 35mg powder for injection vial (82755)

82755

FABRAZYME agalsidase beta-rch 35mg powder for injection vial

Sanofi-Aventis Australia Pty Ltd

May 30, 2002

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/9850611c3eb31fb3861c62eb40c55a5f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/7d1e1c28c833b2b6f61b41863282a8d4.pdf

Active Ingredients

Agalsidase beta

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.